MA vs PPCB · P/E 38, rev $32.79B vs P/E 0.0, $3.9M cap
Mastercard Inc (MA) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
PPCB does not have a complete income-statement cache yet.
MA currently screens at market cap $515.12B and trailing P/E 38.4. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the MA and PPCB stock pages for the full models.
Not investment advice.